Evidence map›Paper›PMID 39274438›Full record

ReviewJournal of clinical medicine2024

Adenomyosis: An Update Concerning Diagnosis, Treatment, and Fertility.

Aikaterini Selntigia, Pietro Molinaro, Silvio Tartaglia, Antonio Pellicer, Daniela Galliano, Mauro Cozzolino

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07065539 (The Impact of Duration of Gonadotropin-Releasing Hormone Agonist Pretreatment and Letrozole Supplementation on Pregnancy Outcomes in Frozen-Thawed Embryo Transfer Cycles for Patients With Adenomyosis), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07065539 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

The Impact of Duration of Gonadotropin-Releasing Hormone Agonist Pretreatment and Letrozole Supplementation on Pregnancy Outcomes in Frozen-Thawed Embryo Transfer Cycles for Patients With Adenomyosis: A 2 by 2 Factorial Multicenter, Randomized Controlled Trial

TypeinterventionalSponsorFirst Affiliated Hospital, Sun Yat-Sen UniversityRan2025 to 2027Enrolled432ConditionsAdenomyosis of Uterus, Frozen Embryo Transfer (FET)ArmsGnRH-a-1M, GnRH-a-2M, GnRH-a+LE-1M, GnRH-a+LE-2M
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Treatment selection for adenomyosis based on imaging findings and patient characteristics.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Observational
  16. Article
  17. A newly identified allelic mutation c.110C>T in theGynecology and pelvic medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aikaterini SelntigiaIVIRMA Global Research Alliance, IVIRMA Roma, 00169 Rome, Italy.ORCID 0000-0002-2467-737X
Pietro MolinaroIVIRMA Global Research Alliance, IVIRMA Roma, 00169 Rome, Italy.ORCID 0000-0003-3895-761X
Silvio TartagliaDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Viale Montpellier 1, 00133 Rome, Italy.ORCID 0000-0001-7013-5937
Antonio PellicerIVIRMA Global Research Alliance, IVIRMA Roma, 00169 Rome, Italy.
Daniela GallianoIVIRMA Global Research Alliance, IVIRMA Roma, 00169 Rome, Italy.
Mauro CozzolinoIVIRMA Global Research Alliance, IVIRMA Roma, 00169 Rome, Italy.ORCID 0000-0002-5929-2357

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review article aims to summarize current tools used in the diagnosis of adenomyosis with relative pharmacological and surgical treatment and to clarify the relative association between adenomyosis and infertility, considering the importance of an accurate diagnosis of this heterogeneous disease. Among different reported concepts, direction invagination of gland cells from the basalis endometrium deep into the myometrium is the most widely accepted opinion on the development of adenomyosis. Adenomyosis has been increasingly identified in young women with pain, AUB, infertility, or no symptoms by using imaging techniques such as transvaginal ultrasound and magnetic resonance. Furthermore, adenomyosis often coexists with other gynecological conditions, such as endometriosis and uterine fibroids, increasing the heterogeneity of available data. However, there is no agreement on the definition and classification of adenomyotic lesions from both the histopathology and the imaging points of view, and diagnosis remains difficult and unclear. A standard, universally accepted classification system needs to be implemented to improve our understanding and inform precise diagnosis of the type of adenomyosis. This could be the key to designing RCT studies and evaluating the impact of adenomyosis on quality of life in terms of menstrual symptoms, fertility, and pregnancy outcome, given the high risk of miscarriage and obstetric complications.

Indexed as

adenomyosisdiagnosisIVFreproductive outcomestreatment

Identifiers

PMID39274438
PMCPMC11396652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.